CAH - NYSE

Cardinal Health, Inc.

CAH·NYSE

$195.85

+0.50%

HealthcareMedical - Distribution

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$45.87B

EPS6.4800

P/E Ratio30.22

Earnings Date08/11/2026

53.12B

Assets

18%

3Y+21.0%

5Y+30.0%

10Y+56.0%

55.76B

Total Liabilities

15%

3Y+25.0%

5Y+43.0%

10Y+102.0%

-2.63B

Total Equity

-18%

3Y+273.0%

5Y-247.0%

10Y-140.0%

Cardinal Health, Inc. Funding & Solvency Profile

CAH · NYSE

Current Assets

Cash & Cash Equivalents3.87B

Net Receivables13.24B

Inventory16.83B

Other Current Assets2.43B

Total Current Assets36 B

Non-Current Assets

Property, Plant & Equipment2.86B

Goodwill & Intangible Assets12.18B

Long-Term Investments14.00M

Other Non-Current Assets1.70B

Total Non-Current Assets5 B

Total Assets

53.12B

Financial Health Analysis

Current Ratio

0.94x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Working Capital

-2524000000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

68% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Cardinal Health, Inc. Balance Sheet

CAH • NYSE

Cardinal Health, Inc. Balance Sheet	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017	Jun 2016	Jun 2015	Jun 2014	Jun 2013	Jun 2012	Jun 2011	Jun 2010	Jun 2009	Jun 2008	Jun 2007	Jun 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	3.9B	5.1B	4.1B	4.7B	3.4B	2.8B	2.5B	1.8B	6.9B	2.4B	4.6B	2.9B	1.9B	2.3B	1.9B	2.8B	1.2B	1.3B	1.3B	1.2B
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	383.7M	132M	498.4M
Cash & Short-Term Investments	3.9B	5.1B	4.1B	4.7B	3.4B	2.8B	2.5B	1.8B	6.9B	2.4B	4.6B	2.9B	1.9B	2.3B	1.9B	2.8B	1.2B	1.7B	1.4B	1.7B
Net Receivables	13.2B	12.1B	11.1B	10.6B	9.1B	8.3B	8.4B	7.8B	8B	7.4B	6.5B	5.4B	6.3B	6.4B	6.2B	5.2B	5.2B	5B	4.7B	3.8B
Accounts Receivables	13.2B	12.1B	11.1B	10.6B	9.1B	8.3B	8.4B	7.8B	8B	7.4B	6.5B	5.4B	6.3B	6.4B	6.2B	5.2B	5.2B	5B	4.7B	3.8B
Inventory	16.8B	15B	16.1B	15.6B	14.6B	13.2B	12.8B	12.3B	11.3B	10.6B	9.2B	8.3B	8.4B	7.9B	7.3B	6.4B	6.8B	6.8B	7.4B	7.5B
Prepaids	0.0	0.0	2.4B	2B	2.8B	1.7B	1.9B	1.9B	2.1B	1.6B	1.4B	1.4B	1.2B	1B	897M	637.1M	523M	591.4M	651.3M	558.8M
Other Current Assets	2.4B	2.7B	72M	0.0	1.1B	0.0	0.0	756M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2B	264.2M	354.8M	3B
Total Current Assets	36.4B	34.9B	33.7B	32.9B	31B	25.9B	25.7B	24.6B	28.3B	22B	21.8B	17.9B	17.8B	17.5B	16.3B	14.9B	21B	14.3B	14.5B	16.6B
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	2.9B	2.5B	2.5B	2.4B	2.4B	2.4B	2.4B	2.5B	1.9B	1.8B	1.5B	1.5B	1.5B	1.6B	1.5B	1.5B	1.5B	1.7B	1.6B	1.5B
Goodwill	9.7B	4.7B	4.6B	5.9B	8B	8.4B	8.4B	8.3B	7.2B	7.2B	5.1B	4.9B	4.6B	4B	3.8B	2.3B	2.3B	6.2B	5.9B	4.3B
Intangible Assets	2.5B	1.7B	1.5B	1.8B	2.1B	2.9B	3.4B	3.9B	2B	2.3B	948M	992M	973M	414M	413M	0.0	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	12.2B	6.5B	6.1B	7.6B	10.1B	11.3B	11.8B	12.2B	9.2B	9.4B	6B	5.9B	5.6B	4.4B	4.3B	2.3B	2.3B	6.2B	5.9B	4.3B
Long-Term Investments	14M	43M	56M	77M	68M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	691.5M	0.0	916.8M	0.0	0.0
Other Non-Current Assets	1.7B	1.2B	1B	876M	883M	1.2B	1.1B	682M	681M	944M	866M	765M	986M	807M	759M	657.8M	405.7M	384.1M	1.1B	1.1B
Total Non-Current Assets	16.7B	10.2B	9.6B	10.9B	13.4B	14.8B	15.2B	15.4B	11.8B	12.2B	8.4B	8.1B	8B	6.8B	6.5B	5.1B	4.1B	9.2B	8.6B	6.9B
Total Assets	53.1B	45.1B	43.3B	43.9B	44.5B	40.8B	41B	40B	40.1B	34.1B	30.1B	26B	25.8B	24.3B	22.8B	20B	25.1B	23.4B	23.2B	23.4B
LIABILITIES
CURRENT LIABILITIES
Total Payables	34.7B	31.8B	29.9B	27.1B	23.7B	21.4B	21.5B	19.7B	17.9B	17.3B	14.4B	12.1B	12.3B	11.7B	11.3B	9.5B	9B	8.3B	9.2B	8.9B
Accounts Payable	34.7B	31.8B	29.9B	27.1B	23.7B	21.4B	21.5B	19.7B	17.9B	17.3B	14.4B	12.1B	12.3B	11.7B	11.3B	9.5B	9B	8.3B	9.2B	8.9B
Other Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1M	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	3.6B	3.4B	3B	2.8B	3B	2.2B	2.1B	2B	2B	1.8B	2.6B	2.2B	2.1B	2B	1.7B	1.8B	1.5B	1.9B	2.2B	1.9B
Short Term Debt	714M	551M	892M	682M	976M	10M	452M	1B	1.3B	587M	281M	801M	168M	476M	326.7M	233.2M	367.3M	159M	16M	199M
Other Current Liabilities	-164M	0.0	42M	0.0	96M	0.0	0.0	213M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4B	50M	34.2M	534.2M
Total Current Liabilities	38.9B	35.6B	33.7B	30.6B	27.6B	23.6B	24.1B	22.9B	21.2B	19.7B	17.2B	15.1B	14.6B	14.2B	13.4B	11.5B	12.3B	10.4B	11.5B	11.6B
NON-CURRENT LIABILITIES
Long Term Debt	7.8B	4.6B	3.9B	4.7B	5.3B	6.8B	7.6B	8B	9.1B	5B	5.2B	3.2B	3.7B	2.4B	2.2B	1.9B	3.3B	3.7B	3.5B	2.6B
Deferred Tax Liabilities (Non-Current)	2.4B	3.1B	3.1B	3B	8.3B	8.6B	2.9B	3B	2.9B	2.8B	1.4B	1.3B	1.6B	1.4B	1.5B	1.3B	847.3M	1.6B	859.9M	771.9M
Other Non-Current Liabilities	5.8B	4.5B	5.1B	5.9B	981M	0.0	0.0	12M	118M	117M	0.0	0.0	0.0	0.0	0.0	0.0	-8.4M	0.0	0.0	0.0
Total Non-Current Liabilities	16.9B	12.7B	12.6B	14B	15B	15.4B	10.5B	11B	12.1B	7.9B	6.6B	4.5B	5.3B	3.8B	3.6B	3.2B	4.1B	5.3B	4.3B	3.4B
Capital Lease Obligations	811M	475M	434M	437M	419M	6.8B	7.6B	8B	9.1B	5B	5.2B	3.2B	3.7B	2.4B	2.2B	1.9B	3.3B	3.7B	3.5B	2.6B
Total Liabilities	55.8B	48.3B	46.3B	44.6B	42.7B	39B	34.6B	33.9B	33.3B	27.6B	23.9B	19.6B	19.8B	18B	17B	14.7B	16.4B	15.7B	15.8B	14.9B
SHAREHOLDERS' EQUITY
Treasury Stock	-6.4B	-5.7B	-4.9B	-3.1B	-2.2B	-2.1B	-1.8B	-1.2B	-731M	-2.8B	-2.2B	-1.4B	-1.1B	-816M	-457.7M	-331M	-343M	-480.7M	-8.2B	-4.5B
Common Stock	3B	2.9B	2.7B	2.8B	2.8B	2.8B	2.8B	2.7B	2.7B	3B	3B	3B	3B	2.9B	2.9B	0.0	0.0	0.0	0.0	0.0
Additional Paid-In Capital	0.0	0.0	0.0	0.0	0.0	0.0	2.8B	2.7B	2.7B	3B	3B	3B	3B	2.9B	2.9B	2.9B	3B	3B	3.9B	3.2B
Retained Earnings	783M	-286M	-642M	-280M	1.2B	1.2B	5.4B	4.6B	5B	6.4B	5.5B	4.8B	4B	4.1B	3.3B	2.6B	6B	5B	11.5B	9.8B
Accumulated Other Comprehensive Income/Loss	-155M	-167M	-151M	-114M	-34M	-104M	-79M	-92M	-125M	-116M	-23M	70M	68M	37M	77M	70M	82.2M	210.8M	121M	33.9M
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	-2.8B	-2.7B	-2.7B	-3B	-3B	-3B	-3B	-2.9B	-2.9B	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	-2.8B	-3.2B	-3B	-709M	1.8B	1.8B	6.3B	6.1B	6.8B	6.6B	6.3B	6.4B	6B	6.2B	5.8B	5.3B	8.7B	7.7B	7.4B	8.5B
Total Equity	-2.6B	-3.2B	-3B	-706M	1.8B	1.8B	6.3B	6.1B	6.8B	6.6B	6.3B	6.4B	6B	6.2B	5.8B	5.3B	8.7B	7.7B	7.4B	8.5B
Minority Interest	147M	1M	1M	3M	3M	3M	2M	0.0	20M	17M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	53.1B	45.1B	43.3B	43.9B	44.5B	40.8B	41B	40B	40.1B	34.1B	30.1B	26B	25.8B	24.3B	22.8B	20B	25.1B	23.4B	23.2B	23.4B
Total Investments	14M	43M	56M	77M	68M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	691.5M	0.0	1.3B	132M	498.4M
Total Debt	9.3B	5.6B	5.2B	5.8B	6.7B	6.8B	8B	9B	10.4B	5.5B	5.5B	4B	3.9B	2.9B	2.5B	2.1B	3.6B	3.8B	3.5B	2.8B
Net Debt	5.5B	476M	1.1B	1.1B	3.3B	4B	5.5B	7.3B	3.5B	3.2B	876M	1.1B	2B	620M	572.7M	-626M	2.4B	2.6B	2.2B	1.6B
Shares Outstanding	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637	237,597,637

SEC Filings

CAH - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	April 30, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 30, 2026	April 30, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 23, 2026	March 17, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 05, 2026	March 02, 2026	2026	View Filing
10-Q 10-Q 2025 Q4 Q4	February 05, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 05, 2026	February 05, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 13, 2026	January 13, 2026	2026	View Filing
8-K 8-K 2025 N/A	November 06, 2025	November 05, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	October 30, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 30, 2025	October 30, 2025	2025	View Filing

Showing 1 to 10 of 570 filings

Related Guides

Blog Categories

Continue your CAH research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.